Learning objectives
After watching this webinar, participants will be able to :
Needs assessment and expected educational outcome
To increase awareness of hypertrophic cardiomyopathy as a risk factor that has led to a paradigm shift in current practices and recommendations regarding exercise for athletes suffering from HCM.
This programme is supported by Bristol-Myers Squibb in the form of an unrestricted financial support. The scientific programme has not been influenced in any way by its sponsor.
Main topic
Session information
This webinar is designed for Cardiologists, Nurses, Allied Professions and those wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).